ClinicalTrials.Veeva

Menu

A Follow-up Study on Total Endoscopic Thyroidectomy Bilateral Areola Approach

Zhejiang University logo

Zhejiang University

Status

Completed

Conditions

Quality of Life

Treatments

Procedure: Endoscopic Thyroidectomy Bilateral Areola Approach

Study type

Interventional

Funder types

Other

Identifiers

NCT05315219
2021-0439

Details and patient eligibility

About

Endoscopic thyroidectomy bilateral areola approach (ETBAA) is one of the most widely applied approach in China, meanwhile its safety and effectiveness has been broadly discussed since being introduced. However, these studies are generally with small sample size and short follow-up duration. The lack of long-term follow-up on oncological outcomes makes it inaccurate to evaluate the effectiveness of ETBAA versus OT. Thus, in this study, we evaluated long-term QoL and outcomes of patients with PTC underwent thyroidectomy via ETBAA versus OT.

Enrollment

295 patients

Sex

Female

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Female patients under 55 years old; 2) no lateral cervical lymph node or distant metastasis were detected before the operation; 3) postoperative pathology confirmed the diagnosis of papillary thyroid carcinoma.

Exclusion criteria

    1. Previous history of thyroid surgery; 2) lateral cervical lymph node dissection in the operation; 3) past or current history of underlying diseases including hyperthyroidism, hypertension, diabetes, coagulation dysfunction.

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

295 participants in 2 patient groups

Endoscopic Thyroidectomy Bilateral Areola Approach
Experimental group
Treatment:
Procedure: Endoscopic Thyroidectomy Bilateral Areola Approach
Open Thyroidectomy
No Intervention group

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems